Clinical Trial Update: Rifaximin as a Prophylaxis of Spontaneous Bacterial Peritonitis in Comparison With Ciprofloxacin [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rifaximin to ciprofloxacin for prophylaxis of spontaneous bacterial peritonitis (SBP) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Bacterial Peritonitis

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)
• Rifaximin (rifaximin)

Snippet

Sponsor: Ain Shams University | Conditions: Spontaneous Bacterial Peritonitis | Phase 3 | Status: COMPLETED